Simplex Trading’s Standard BioTools LAB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-9,200
| Closed | -$16K | – | 9110 |
|
|
2024
Q4 | $16K | Sell |
9,200
-3,900
| -30% | -$7.26K | ﹤0.01% | 6857 |
|
|
2024
Q3 | $25K | Sell |
13,100
-8,500
| -39% | -$16.6K | ﹤0.01% | 6500 |
|
|
2024
Q2 | $38K | Buy |
+21,600
| New | +$52.8K | ﹤0.01% | 6345 |
|
|
2023
Q3 | – | Sell |
-1,000
| Closed | -$1K | – | 9275 |
|
|
2023
Q2 | $1K | Sell |
1,000
-20,600
| -95% | -$40.7K | ﹤0.01% | 8646 |
|
|
2023
Q1 | $42K | Buy |
21,600
+18,200
| +535% | +$36K | ﹤0.01% | 6118 |
|
|
2022
Q4 | $3K | Buy |
3,400
+100
| +3% | +$123 | ﹤0.01% | 8383 |
|
|
2022
Q3 | $3K | Buy |
3,300
+200
| +6% | +$302 | ﹤0.01% | 9108 |
|
|
2022
Q2 | $4K | Sell |
3,100
-40,100
| -93% | -$99.2K | ﹤0.01% | 8989 |
|
|
2022
Q1 | $92K | Buy |
43,200
+27,800
| +181% | +$96K | ﹤0.01% | 6273 |
|
|
2021
Q4 | $60K | Sell |
15,400
-43,200
| -74% | -$202K | ﹤0.01% | 7006 |
|
|
2021
Q3 | $358K | Hold |
58,600
| – | – | ﹤0.01% | 4629 |
|
|
2021
Q2 | $360K | Buy |
58,600
+58,291
| +18,864% | +$312K | ﹤0.01% | 4674 |
|
|
2021
Q1 | $139K | Buy |
309
+233
| +307% | +$1.28K | ﹤0.01% | 5289 |
|
|
2020
Q4 | $45K | Sell |
76
-374
| -83% | -$2.46K | ﹤0.01% | 6299 |
|
|
2020
Q3 | $334K | Buy |
450
+332
| +281% | +$2.29K | ﹤0.01% | 3485 |
|
|
2020
Q2 | $47K | Buy |
118
+112
| +1,867% | +$390 | ﹤0.01% | 5552 |
|
|
2020
Q1 | $1K | Sell |
6
-9
| -60% | -$30 | ﹤0.01% | 7371 |
|
|
2019
Q4 | $5K | Buy |
15
+3
| +25% | +$11 | ﹤0.01% | 6694 |
|
|
2019
Q3 | $5K | Buy |
12
+11
| +1,100% | +$87 | ﹤0.01% | 6612 |
|
|
2019
Q2 | $1K | Sell |
1
-14
| -93% | -$178 | ﹤0.01% | 6876 |
|
|
2019
Q1 | $19K | Buy |
+15
| New | +$158 | ﹤0.01% | 5747 |
|
|
2018
Q4 | – | Sell |
-403
| Closed | -$301K | – | 7427 |
|
|
2018
Q3 | $301K | Buy |
+403
| New | +$2.87K | ﹤0.01% | 3177 |
|
|
2018
Q2 | – | Sell |
-460
| Closed | -$29K | – | 7642 |
|
|
2018
Q1 | $29K | Buy |
+460
| New | +$3.02K | ﹤0.01% | 2981 |
|
|
2017
Q4 | – | Sell |
-125
| Closed | -$4K | – | 6334 |
|
|
2017
Q3 | $4K | Buy |
125
+58
| +87% | +$244 | ﹤0.01% | 4567 |
|
|
2017
Q2 | $10K | Buy |
67
+37
| +123% | +$175 | ﹤0.01% | 3970 |
|
|
2017
Q1 | $3K | Buy |
+30
| New | +$190 | ﹤0.01% | 5014 |
|
|
2016
Q4 | – | Sell |
-31
| Closed | -$2K | – | 6205 |
|
|
2016
Q3 | $2K | Buy |
+31
| New | +$285 | ﹤0.01% | 4966 |
|
|
2016
Q1 | – | Sell |
-75
| Closed | -$8K | – | 5919 |
|
|
2015
Q4 | $8K | Buy |
75
+24
| +47% | +$236 | ﹤0.01% | 3503 |
|
|
2015
Q3 | $86K | Buy |
51
+42
| +467% | +$661 | 0.01% | 1531 |
|
|
2015
Q2 | $3K | Buy |
+9
| New | +$284 | ﹤0.01% | 4055 |
|
|
2015
Q1 | – | Sell |
-37
| Closed | -$3K | – | 5268 |
|
|
2014
Q4 | $3K | Buy |
+37
| New | +$1.05K | ﹤0.01% | 3479 |
|
Other funds holding LAB
CC
MCO
LFCM
VCM
HBWM
Simplex Trading's LAB Position: Q1 2026 in Review
Simplex Trading opened a new position in Standard BioTools (LAB) in Q1 2026: 2,915 shares worth $2.68K. The stake represents ﹤0.01% of the portfolio and ranks #8252 among its holdings. This is a return to the name: Simplex Trading previously reported a position in LAB as recently as Q1 2025.
Simplex Trading first reported a position in LAB in Q4 2014 and has held it in 32 quarters since. The position peaked at $221K in Q3 2020. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.
- Simplex Trading held 2,915 shares of Standard BioTools worth $2.68K as of Q1 2026.
- Standard BioTools was a new Simplex Trading position in Q1 2026.
- Standard BioTools made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #8252 holding.
- Simplex Trading first reported a position in Standard BioTools in Q4 2014 and has held it in 32 quarters since.
- Simplex Trading's Standard BioTools position peaked at $221K in Q3 2020.
- 155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.